The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, ...

While many recognize Mia Hamm as a legendary soccer player and two-time Olympic gold medalist, she has also become a ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

PRINCETON, NJ, USA & TOKYO, Japan I March 31, 2025 I Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd.

Novo Nordisk’s diabetes pill Rybelsus, an oral semaglutide, reduced the risk of major heart-related events by 14% in adults with Type 2 diabetes and cardiovascular disease or chronic kidney disease, ...

Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy to reduce the ...

Try Now>> See today’s best-performing stocks on TipRanks Unicycive Therapeutics NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

New Drug Application for hyperphosphatemia in chronic kidney disease patients on dialysis under review by the FDA with a ...

Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor ...

Injectable semaglutide has better bioavailability, researchers say, but the many patients who want an oral drug are an unmet ...